Aclaro description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Aclaro

Innocutis

Aclaro Emulsion


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Description



Rx only
For topical use only
Not for ophthalmic use






Aclaro











Clinical Pharmacology


2

Aclaro Indications and Usage

Aclaro® is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting rom the use of oral contraceptives, pregnancy, hormone replacment therapy, or skin trauma.

Contraindications



Warnings














Precautions


See Warnings:

Pregnancy Category C



Nursing Mothers

Nursing mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when hydroquinone is used by a nursing mother.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Pediatric usage

Safety and effectiveness in pediatric patients below the age of 12 years have not been established.

Dosage and Administration

Side Effects



Overdosage Section


There have been no systemic reactions reported from the use of topicalshydroquinone.However, treatment should be limited to relatively small areas of thesbody at one time, since some patients experience a transient skin reddening and a mildsburning sensation which does not preclude treatment.


Dosage and Administration



How Supplied
















Aclaro

Aclaro

Hydroquinone EMULSION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:68712-003
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Hydroquinone HYDROQUINONE 40 mg

Inactive Ingredients

Ingredient Name Strength
ASCORBIC ACID
BENZYL ALCOHOL
AVOBENZONE
ALKYL (C12-15) BENZOATE
cetearyl ethylhexanoate
CETYL ALCOHOL
CETYL ESTERS WAX
cetyl palmitate
CETYL PHOSPHATE
DIMETHICONE
EDETATE DISODIUM
OCTINOXATE
GLYCERIN
GLYCOLIC ACID
SODIUM GLYCOLATE
HYDROXYETHYL CELLULOSE (140 CPS AT 5%)
PHENOXYETHANOL
water
SODIUM METABISULFITE
STEARIC ACID

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68712-003-01 48.2 in 1 BOTTLE, PUMP
2 NDC:68712-003-02 3 in 1 PACKET

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2004-06-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.